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Dietary Se levels in the UK have fallen over the last 20 years and recent surveys indicate that
average Se intakes are 30–40mg/d, which is well below the current UK reference nutrient
intake for adult men (75mg/d) or women (60mg/d). Functional consequences of this decline
have not been recognised, although epidemiological data suggest it may contribute to increased
risk of infections and incidence of some cancers. Previous data have indicated that biochemical
changes in Se-dependent proteins occur in otherwise healthy UK subjects given small Se
supplements. The current studies have focused on the effect of small Se supplements on the
immune response since there is evidence of specific interactions between Se intake and viral
replication, and since the potential anti-cancer effects of Se may be mediated by non-
antioxidant effects of Se such as changes in immune function. Data indicate that subjects given
small Se supplements (50 or 100mg Se/d) have changes in the activity of Se-dependent
enzymes and evidence of improved immune function and clearance of an administered live
attenuated virus in the form of poliovirus vaccine. Responses of individual subjects to Se
supplements are variable, and current work is evaluating potential explanations for this
variability, including genetic variability and pre-existing Se status.
Selenium intake: Selenium supplements: Immune response: Se-dependent proteins
There is clear evidence that the dietary intake of Se has
fallen in the UK and other western European countries
over the last 20 years. Dietary survey data published by the
UK Government indicate that the average intake may be as
low as 30–40mg/d (Ministry of Agriculture, Fisheries and
Food, 1997) compared with values of approximately 60 mg/
d reported in 1974. The UK reference nutrient intake (RNI)
for Se is 75mg/d for adult men and 60mg/d for adult
women (Department of Health, 1991). Rayman (1997) has
compiled retrospective data indicating that this fall in
dietary intake has been accompanied by a dramatic fall in
circulating Se concentrations, and this finding has been
supported by recent intervention studies and survey data
examining UK subjects in specific geographical areas
(Brown et al. 2000; Bates et al. 2002; Broome et al. 2004).
Data on the distribution of Se in foodstuffs indicate that
meat and meat products contribute >30% of the Se intake
in the UK (Ministry of Agriculture, Fisheries and Food,
1997), and therefore it might be predicted that vegetarians
or vegans are at specific risk. A small amount of data is
supportive of this risk (Ministry of Agriculture, Fisheries
and Food, 2000), but this finding is not universal. In the
elderly there is evidence from international studies that Se
levels are reduced (Berr et al. 1993; Olivieri et al. 1994,
1995), but again the small amount of data available from
the UK is contradictory (Campbell et al. 1989; Bates et al.
2002).
Whether the relatively low levels in the UK diet have
any functional importance is the subject of considerable
debate. Rayman (1997, 2000) has argued persuasively that
UK intakes are sufficiently low to warrant government
intervention to help reduce the incidence of a number of
chronic disorders, including various cancers and CVD,
although the relevant UK Government expert committee
(Department of Health, 1998) have concluded that inter-
vention is not warranted.
Effects of selenium deficiency
Overt Se deficiency has been associated with dilated
cardiomyopathy, skeletal muscle myopathy, osteoarthro-
pathy and cretinism (in I-deficient populations), while
more marginal deficiencies have been linked to increased
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occurrence of some cancers, increased viral disease and a
reduced immune function (Rayman, 1997, 2000). Keshan
disease is a severe endemic cardiomyopathy that occurred
in the Keshan region of China. It was localised primarily in
areas with low soil Se content and has been effectively
eliminated by Se supplementation, although an infectious
agent is also thought to play a role (Ge & Yang, 1993). A
Se-responsive joint disorder, Kashin-Beck disease, has also
been reported in low Se areas of China. In animals Se
deficiency is associated with a wider range of features, and
when in combination with vitamin E deficiency in farm
animals can cause commercially-important myopathies of
cardiac and skeletal muscle (white muscle disease).
The level of dietary Se at which overt deficiency
disorders become apparent in man is not clear. Countries
such as New Zealand have long been recognised to have
extensive regions with Se-deficient soils, although no overt
human Se-deficiency disorders have been recognised.
Epidemiological studies have linked low Se levels to an
increased risk of specific cancers, including cancers of the
lung, prostate, oesophagus and colon (Combs, 2001), and
cancer mortality rates have been found to be markedly
lower in areas of the USA with higher Se intakes compared
with those where levels are lower (Clark et al. 1991). An
apparent link between low Se levels and increased risk of
cardiovascular disorders has also been identified by epi-
demiological studies (Salonen et al. 1982; Virtamo et al.
1985; Beaglehole et al. 1990).
Both animal and human studies have highlighted a link
between Se status and immune function. In experimental
models marginal Se deficiency can affect all components
of the immune system, including the development and
expression of humoral and cell-mediated responses to non-
specific stimuli, leading to a general immunosuppression
(Bonomini et al. 1995; Taylor, 1995; Finch & Turner,
1996; McKenzie et al. 1998; Combs, 2001). Se supple-
mentation in experimental animals has been associated
with increases in natural killer cell activity, T-cell
proliferation, lymphokine-activated killer cell activity,
delayed-type hypersensitivity skin responses and vaccine-
induced immunity (McKenzie et al. 1998; Combs, 2001).
Less clear evidence links dietary Se with human immune
function, although supplementation with Se has been
reported to increase proliferation of peripheral blood
lymphocytes in response to mitogen (Peretz et al. 1991;
Roy et al. 1994), increase the expression of high-affinity
IL-2 receptor (Roy et al. 1994) and improve cytotoxic
lymphocyte-mediated tumour cytotoxicity and natural
killer cell activity (Kiremidjian-Schumacher et al. 1994).
Se deficiency has also been linked to the occurrence,
virulence or disease progression of some viral infections,
including HIV (Beck et al. 1995, 1998; Taylor, 1997).
Beck et al. (1995, 1998) have reported findings that
directly link Se deficiency with the virulence of RNA
viruses. In Se-deficient mice the harmless Pircorna virus
coxsackie B3 becomes cardiotoxic. When Se-deficient or
glutathione peroxidase (GPx)-knock-out mice are inocu-
lated with the benign strain of the coxsackie virus,
mutation occurs in the genome to give a cardio-virulent
form of the virus that causes myocarditis. This deficiency-
driven evolution of pathogenicity is stable and daughter
coxsackie virus isolates from the Se-deficient mice retain
their newly-acquired cardio-virulence. The mechanisms
are unclear, but may be a result of either an increased
replication rate of virus in hosts with impaired immunity or
to increased free radical damage to the viral genome (Beck
et al. 1998).
Approaches to understanding the functional effects
of a relative selenium lack
Evaluation of whether the relative deficit in UK subjects
has functional consequences has been complex. The major
approach followed has been to examine the responses of
volunteer subjects to levels of Se supplementation that
will result in a total intake exceeding the RNI. Arthur
and colleagues (Brown et al. 2000), in Aberdeen, have
examined the effect of small Se supplements on the
activity of Se-dependent enzymes in leucocytes of other-
wise healthy Scottish individuals. They have found that
50mg Se/d causes variable increases in the activity of GPx,
the magnitude of the changes being inversely related to
the baseline activity. Thus, the inference is that subjects
with the lowest initial Se status show the largest rise in Se-
dependent enzyme activities following Se supplementation.
An alternative approach to the evaluation of whether the
relative deficit in UK subjects has functional effects would
be potentially to study the effect of Se supplements on the
incidence of specific cancers or cardiovascular disorders.
This type of approach is complicated by the large number
of subjects that must participate in order to provide
Table 1. Summary of effects of selenium supplementation on lymphocyte function (data from Broome et al. 2004)*
Group supplemented with:
50mg Se 100mg Se
T lymphocyte proliferation Increase compared with placebo Increase compared with placebo
Interferon-g release Increase compared with placebo Increase compared with placebo
and 50mg groups
IL-10 release Increase compared with placebo Increase compared with placebo
IL-2 release No significant effect No significant effect
IL-4 release No significant effect No significant effect
*Groups of adult UK subjects with relatively low plasma Se concentrations (<1.2mmol/l, approximately 60% of the total screened) were allocated to one of
three groups that received daily supplements of 50 or 100 mg Se (as sodium selenite) or placebo for 15 weeks.
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sufficient discrimination (i.e. ‘power’) for the study in
which disease incidence is used as an end point, and by
data demonstrating that Se supplements may affect disease
incidence even where baseline diets exceed the RNI for Se.
Clark et al. (1996), in a long-term double-blind placebo-
controlled study in 1312 individuals in the USA, have
found that supplementation with 200 mg Se/d reduces the
incidence of prostate, colo-rectal and lung cancer by 63,
58 and 45% respectively. Total cancer mortality and
incidence are also reduced. The baseline dietary Se intake
for these subjects, approximately 90mg/d, is in excess of
the UK values and the RNI for this nutrient.
In the third type of approach the effects of Se
supplementation on immune function and the rates of
clearance and mutation of a Picorna virus in otherwise
healthy UK subjects have been examined (Broome et al.
2004). Groups of adult UK subjects with relatively low
plasma Se concentrations (<1.2mmol/l; approximately
60% of the total screened) were allocated to one of three
groups that received daily supplements of 50 or 100mg Se
(as sodium selenite) or a placebo for 15 weeks. All sub-
jects received an oral live attenuated poliomyelitis vaccine
6 weeks after commencing the Se supplement or placebo
and an intravenous injection of enriched stable 74Se 3
weeks later. All analyses were undertaken in a double-
blind manner. The Se-supplemented groups were reported
to have increased plasma Se concentrations, an increase
in their body exchangeable Se pool (measured from
dilution of the intravenous 74Se) and an increase
in lymphocyte phospholipid GPx and cytosolic GPx
activities. Se supplements were found to augment cellular
immune response by increased production of interferon-g
and other cytokines, an earlier peak T-cell proliferation
and an increase in the T-helper cell population (Table 1),
although the humoral immune response was unaffected.
The functional effect of this enhanced immune response
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Fig. 1. Percentage of subjects in which poliovirus was detected in
faeces at 7, 14 and 21 d post polio vaccination. Groups of UK adult
subjects with relatively low plasma Se concentrations (<1.2mmol/l;
approximately 60% of the total screened) were either given 50 (&)
or 100 ( ) mg selenium (as sodium selenite)/d or placebo (%) for
6 weeks before vaccination. Mean values were significantly
different from those for the placebo group at the same time point:
*P < 0.001. (Data derived from Broome et al. 2004.)
Increasing dietary Se intake
Blood Se content
GPx1 activity
Activities of other
selenoproteins
Non-protein effects 
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Fig. 2. Hypothetical representation of the effect of changing dietary selenium intake on
circulating selenium content, selenium-dependent enzyme activities and functional effects
of selenium that are not related to selenoproteins. The range of optimum intake for
selenium functions is assumed to require both maximum selenoprotein activity and
stimulation of non-protein effects without inducing toxicity. GPx1, glutathione peroxidase 1.
(——), Variables for which reasonable experimental data are available and to which values
can be ascribed; (....), hypothetical relationships for which no experimental data are
currently available.
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was demonstrated by a more rapid clearance of the
poliovirus in the supplemented subjects (Fig. 1). Analysis
of the RT–PCR products from faecal samples indi-
cated that the recovered poliovirus product from Se-
supplemented subjects contains a lower number of mutations
(Broome et al. 2004).
The conclusion from these data is that these UK subjects
have a functional Se deficit leading to a suboptimal
immune status and deficit in viral handling. Careful
examination of these data also illustrates that there is
substantial inter-subject variability in responses. It also
seems clear that there is no direct correlation between the
change in activity of Se-dependent enzymes and functional
changes in immune status. Most notably, supplementation
with 50 mg Se causes no marked increase in lymphocyte or
granulocyte GPx activities (GPx1 or GPx4), but does cause
marked changes in cytokine responses of lymphocytes
(Table 1) and influences viral handling by the gut (Fig. 1;
Broome et al. 2004).
Such data suggest that alternative modes of action of Se
may play a role in the functional responses seen. GPx1
(cytosolic GPx) has previously been claimed to be a
storage protein for Se (Burk, 1989) and, once saturated,
any further absorbed Se may not be specifically incorpo-
rated into selenoproteins but may increase the level of the
seleno-metabolite pool. These small seleno-metabolites are
of growing interest, as it has recently been demonstrated in
cell culture that they can directly modulate a number of
cellular processes, including NF-kB and other transcription
factors, apoptosis and cell cycle arrest (Gasparian et al.
2002). These metabolites have also been shown to affect
viral replication within infected cells (Cermelli et al.
2002). Thus, it may be that saturation of protein pools of
Se is required in order to achieve maximum functional
benefit. However, Se toxicity is reported to occur at
relatively low levels of supplementation, with the max-
imum safe recommended intakes being as low as 400 mg/d
in the USA (Food and Nutrition Board, 2000) and 450 mg/d
(Department of Health, 1991) in the UK. A schematic
illustration of these concepts is shown in Fig. 2.
In conclusion, recent data indicate clearly that UK
subjects given small Se supplements show responses that
indicate they initially had a functional Se deficit leading to
a suboptimal immune status and deficit in viral handling.
However, further research is clearly required to resolve the
precise level of additional supplements that will provide
optimum benefit and the mechanism of action of the
additional Se.
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